Erythropoietin levels in patients with sleep apnea: a meta-analysis.

Related Articles

Erythropoietin levels in patients with sleep apnea: a meta-analysis.

Eur Arch Otorhinolaryngol. 2017 Mar 09;:

Authors: Zhang XB, Zeng YM, Zeng HQ, Zhang HP, Wang HL

Abstract
Currently available data regarding the blood levels of erythropoietin (EPO) in sleep apnea (SA) patients are contradictory. The aim of the present meta-analysis was to evaluate the EPO levels in SA patients via quantitative analysis. A systematic search of Pubmed, Embase, and Web of Science were performed. EPO levels in SA group and control group were extracted from each eligible study. Weight mean difference (WMD) or Standard mean difference (SMD) with 95% confidence interval (CI) was calculated by using fixed-effects or random effect model analysis according to the degree of heterogeneity between studies. A total of 9 studies involving 407 participants were enrolled. The results indicated that EPO levels in SA group were significantly higher than that in control group (SMD 0.61, 95% CI 0.11-1.11, p = 0.016). Significantly higher EPO levels were found in patients with body mass index <30 kg/m(2), and cardiovascular complications in the subsequent subgroup analysis (both p < 0.05). High blood EPO levels were found in SA patients in the present meta-analysis.

PMID: 28280920 [PubMed - as supplied by publisher]

http://ift.tt/2mwLQZT